There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cytokinetics (CYTK – Research Report), Resmed (RMD – Research Report) and BioSig Technologies (BSGM – Research Report) with bullish sentiments.
Cytokinetics (CYTK)
In a report released today, Salim Syed from Mizuho Securities maintained a Buy rating on Cytokinetics, with a price target of $80.00. The company’s shares closed last Thursday at $45.35, close to its 52-week high of $49.41.
According to TipRanks.com, Syed is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
Currently, the analyst consensus on Cytokinetics is a Strong Buy with an average price target of $63.82, representing a 43.7% upside. In a report issued on June 30, Piper Sandler also maintained a Buy rating on the stock with a $72.00 price target.
See the top stocks recommended by analysts >>
Resmed (RMD)
In a report issued on July 6, David Low from J.P. Morgan maintained a Buy rating on Resmed, with a price target of $255.00. The company’s shares closed last Thursday at $220.28.
According to TipRanks.com, Low is a 2-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Resmed with a $202.64 average price target, representing a -6.6% downside. In a report issued on June 29, CLSA also maintained a Buy rating on the stock with a price target.
BioSig Technologies (BSGM)
In a report released today, Gregory Aurand from Noble Financial maintained a Buy rating on BioSig Technologies, with a price target of $4.00. The company’s shares closed last Thursday at $0.67, close to its 52-week low of $0.55.
According to TipRanks.com, Aurand is ranked #7611 out of 7920 analysts.
BioSig Technologies has an analyst consensus of Moderate Buy, with a price target consensus of $4.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on CYTK:
- Analysts Offer Insights on Financial Companies: Chubb (CB), CBRE Group (CBRE) and Cubesmart (CUBE)
- Analysts’ Top Industrial Goods Picks: 3M (MMM), Fastenal Company (FAST)
- Atlas to Participate in the CJS Securities 22nd Annual New Ideas Summer Conference
- First Commonwealth to Host Second Quarter 2022 Earnings Conference Call on Wednesday, July 27, 2022
- Optinose Announces Additional Positive Results from ReOpen2 and Initial Results from Pooled Analyses of Both Trials in the ReOpen Program
